Omnicell Announces Director Changes and Compensation Details
Ticker: OMCL · Form: 8-K · Filed: Mar 4, 2025 · CIK: 926326
| Field | Detail |
|---|---|
| Company | Omnicell, Inc. (OMCL) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: OMCL
TL;DR
Omnicell board shakeup: Director out, new director in, exec comp details filed.
AI Summary
Omnicell, Inc. filed an 8-K on March 4, 2025, reporting the departure of Director Dr. Robert L. Johnson and the election of new Director Dr. David L. Schlotterbeck. The filing also disclosed compensatory arrangements for certain officers, though specific details and dollar amounts were not provided in this section of the report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine board and officer changes and compensation disclosures, which are common and typically do not represent significant new risks.
Key Players & Entities
- Omnicell, Inc. (company) — Registrant
- Dr. Robert L. Johnson (person) — Departing Director
- Dr. David L. Schlotterbeck (person) — Newly Elected Director
FAQ
Who has departed from Omnicell's board of directors?
Dr. Robert L. Johnson has departed from Omnicell's board of directors.
Who has been elected as a new director to Omnicell's board?
Dr. David L. Schlotterbeck has been elected as a new director to Omnicell's board.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on March 4, 2025.
What is Omnicell, Inc.'s state of incorporation?
Omnicell, Inc. is incorporated in Delaware.
What specific compensatory arrangements for officers are mentioned in the filing?
The filing mentions compensatory arrangements of certain officers, but the specific details and dollar amounts are not provided in the excerpt.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 by Dr. Robert L. Johnson regarding OMNICELL, INC. (OMCL).